Skip to main content

Table 3 Adverse Events of Chemotherapy in the Two Groups

From: Oxaliplatin-dacarbazine combination chemotherapy for the treatment of advanced soft tissue sarcoma of the limbs

AE Grade (CTCAEv3.0) Experimental group (cases) Control group (cases) p value
Nausea 1 (mild) 9 10 >0.05
  2 (moderate) 4 5  
Vomiting 1 (mild) 5 7 >0.05
  2 (moderate) 1 1  
Asthenia 1 (mild) 6 4 >0.05
  2 (moderate) 0 0  
Granulocytopenia 1 (mild) 7 8 >0.05
  2 (moderate) 2 0  
Anaemia 1 (mild) 2 1 >0.05
  2 (moderate) 0 0  
Peripheral Neuropathy 1 (mild) 12 0 Not Comparable
  2 (moderate) 3 0